v3.26.1
Net Loss Per Share
6 Months Ended
Jun. 30, 2026
Earnings Per Share [Abstract]  
Net Loss Per Share

Note 2 — Net Loss Per Share

The following instruments were excluded from the computation of diluted net loss per share for the periods presented because their effect would have been antidilutive (in thousands):

 

 

June 30, 2026

 

 

June 30, 2025

 

Options to purchase common stock

 

 

10,776

 

 

 

11,621

 

Restricted stock and performance units

 

 

2,941

 

 

 

2,441

 

Shares issuable related to the ESPP

 

 

16

 

 

 

22

 

Shares issuable upon conversion of 2026 Notes

 

 

 

 

 

2,003

 

Shares issuable upon conversion of 2027 Notes

 

 

2,751

 

 

 

10,572

 

Shares issuable upon conversion of 2031 Notes

 

 

10,962

 

 

 

 

Total shares

 

 

27,446

 

 

 

26,659

 

 

During the three months ended June 30, 2026, holders converted the remaining $21.1 million aggregate principal amount of the 2026 Notes into 2,002,817 shares of the Company's common stock. There are no outstanding 2026 Convertible Notes as of June 30, 2026.